Biosimilar User Fee Negotiations Under Way; Timetable Compressed
FDA has started biosimilar user fee negotiations with industry, although it does not appear the room is overcrowded with participants.
FDA has started biosimilar user fee negotiations with industry, although it does not appear the room is overcrowded with participants.